Literature DB >> 16011126

Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway.

Zhen Dong1, Zhanquan Yang, Chengshuo Wang.   

Abstract

BACKGROUND: Epithelium of nasal mucosa is the first line of defense against invading pathogens. This study investigated the expression of Toll-like receptor (TLR) 2 and TLR4 in epithelial cells of nasal mucosa and understood the role of TLRs in the innate immunity of nasal mucosa.
METHODS: Human nasal epithelial cells were obtained by scraping the middle one-third of inferior turbinates from 30 patients with chronic rhinosinusitis and 20 healthy adult volunteers. The epithelial cells are made into smears. In situ hybridization was performed for TLR2 and TLR4 messenger RNA (mRNA).
RESULTS: TLR2 and TLR4 mRNA were expressed in the nasal epithelial cells. The expression of the two genes was significantly higher in the chronic rhinosinusitis group than in the normal control (TLR2, t = 8.605, p < 0.0005; TLR4, t = 9.050, p < 0.0005).
CONCLUSION: This study is the first to establish the presence of both TLR2 and TLR4 mRNA on epithelial cells of nasal mucosa, and their expression can be up-regulated in infectious conditions. These results show that TLR2 and TLR4 may play a important role in local host defense of nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011126

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  19 in total

1.  Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33.

Authors:  Douglas D Reh; Yadong Wang; Murugappan Ramanathan; Andrew P Lane
Journal:  Am J Rhinol Allergy       Date:  2010 Mar-Apr       Impact factor: 2.467

Review 2.  Innate immune responses to environmental allergens.

Authors:  Henk F Kauffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

Review 3.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

4.  Relationship of TLR2, TLR4 and tissue remodeling in chronic rhinosinusitis.

Authors:  Xin Wang; Chunyuan Zhao; Wenjun Ji; Yuan Xu; Huamin Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis.

Authors:  Andor Hirschberg; Maria Kiss; Edit Kadocsa; Hilda Polyanka; Kornelia Szabo; Zsolt Razga; Zsolt Bella; Laszlo Tiszlavicz; Lajos Kemeny
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-30       Impact factor: 2.503

6.  Presence of functional TLR2 and TLR4 on human adipocytes.

Authors:  Sandrine Bès-Houtmann; Régis Roche; Laurence Hoareau; Marie-Paule Gonthier; Franck Festy; Henri Caillens; Philippe Gasque; Christian Lefebvre d'Hellencourt; Maya Cesari
Journal:  Histochem Cell Biol       Date:  2006-09-19       Impact factor: 4.304

Review 7.  Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.

Authors:  Chunwei Li; Li Shi; Yan Yan; Bruce R Gordon; William M Gordon; De-Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

Review 8.  Perspectives on the etiology of chronic rhinosinusitis.

Authors:  Bruce K Tan; Robert P Schleimer; Robert C Kern
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

9.  Epithelial genes in chronic rhinosinusitis with and without nasal polyps.

Authors:  Sara L Richer; Ai Q Truong-Tran; David B Conley; Roderick Carter; David Vermylen; Leslie C Grammer; Anju T Peters; Rakesh K Chandra; Kathleen E Harris; Robert C Kern; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008 May-Jun

10.  Lacticaseibacillus casei AMBR2 Restores Airway Epithelial Integrity in Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Katleen Martens; Ilke De Boeck; Katarina Jokicevic; Filip Kiekens; Ricard Farré; Olivier M Vanderveken; Sven F Seys; Sarah Lebeer; Peter W Hellings; Brecht Steelant
Journal:  Allergy Asthma Immunol Res       Date:  2021-07       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.